Higher resting heart rates are seen in women. The development of heart failure and unheralded (coronary or arrhythmic) fatality risk relates to high resting heart rate, and this is most pronounced in men. The study from the UK, reported by Archangelidi et al. 1 in this issue of the Journal, adds to the current body of evidence on the meaning of heart rate in a primary care setting. But what is a normal heart rate, and how does it affect heart disease in men and women?
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The meaning of heart rate In understanding longevity and cardiovascular health, a prominent role has been attributed to the behaviour of heart rate. Across several species, lower heart rate drives longevity. 2 In man, the evaluation and reduction of cardiovascular risk remain at the cornerstone of contemporary care. Increasingly, heart rate is identified as a biomarker and emerges as a potential tool for clinical decision making, which in turn might provide hope of identifying novel targets for intervention or tailoring preventive therapies to those at highest risk from circulatory disease events. Measurement of resting heart rate is broadly accessible and widespread in both health and disease, and, particularly with the advent of use of heart rate monitors in everyday life, facilitating health behaviour changes, increasing numbers of patients and health care providers are rightly questioning the prognostic value, normal values and implications of resting heart rate.
The role of gender
Meanwhile, doctors are increasingly beginning to appreciate and become aware of key gender differences in the pathophysiology of cardiovascular disease. Differences between the female and male heart are now well established. Both resting heart rate and heart rate variability 3, 4 are different between the genders, as well as the distribution of other risk factors. 5 In this respect, we already know that heart rate seems to partly reflect other risk factors, and is therefore largely a prognostic indicator of cardiovascular disease, as demonstrated in a large population study at young/ middle age in Norway. 4 In the current study by Archangelidi et al., the authors use a large-scale powerful dataset of data in participants on average 58 years old, with no prior cardiovascular disease, who underwent a heart rate measurement for several indications. Nearly a quarter of a million (mainly healthy) participants, followed up for three years using national registers of mortality and hospitalization, were investigated. Participants originated from a primary care setting, as a subset of the Clinical research using LInked Bespoke studies and Electronic health Records (CALIBER) registry, which enabled the authors to highlight these questions and refine thresholds into what resting heart rate means for prognosis. The study confirms the finding that basal heart rate, sampled on random primary care visits, is on average higher in women (77.9bpm) than in men (74.6bpm). In both men and women, a higher resting heart rate appeared to be a potent prognostic marker for cardiovascular events, with highly significant effects in fully adjusted models, mostly pronounced in heart failure and unheralded coronary death. Interestingly, disparities were found between women, in whom the threshold of 80 bpm was found for risk, and men, in whom the threshold was lower (70 bpm).
Practical considerations at the individual patient level
These remarkable findings trigger curiosity, in patients as well as care providers and scientists. It is puzzling that -according to Eurostat -women have a higher life expectancy while exhibiting higher resting heart rates, and consequently would be expected to encounter cardiovascular endpoints more frequently. The average life expectancy in the EU was 83.3 years for women and 77.9 years for men, a difference of 5½ years.
The authors propose that we should rethink the normal values for resting heart rate. But is this really the case? From a clinician's perspective, other biomarkers, such as high sensitivity C-reactive protein (hsCRP), have also been shown to correlate with clinical endpoints, and these associations exist within normal range values. Comparably to the current study, the clinician has to be careful about extrapolating to the individual level. On the other hand, risk calculators such as CHADS2-VASC in the setting of atrial fibrillation and Systematic COronary Risk Evaluation (SCORE) are also derived from large registries and studies, and are already influencing clinical decisions every day by correct risk estimation 7 in the extramural domain and at the bedside.
Despite the fact that we can currently only speculate on the mechanisms, the article also discusses the influence of higher heart rates and arrhythmic risk. This might not be a direct electrophysiological effect in the sense of ion channel make-up, but structural heart disease (heart failure, vascular disease) might be involved. In this respect, the autonomic nervous system may play a role, which may extend beyond heart rate decrease. Anti-adrenergic activity, both centrally and pre/and post-synaptically, may be followed by increases in nitric oxide and anti-inflammatory effects at the molecular level. Vagal activity has been shown in an experimental setting to provide anti-arrhythmic protective effects, particularly in the ischaemic heart. 8 Still, electrophysiological mechanisms such as reduced repolarization reserve might play a role in the observed association, and further studies could provide more insight in this direction.
Ambient exposures and co-morbidities
This study alludes to lowering heart rate to reduce CV risk, and studying the effect of lowering heart rate in an at-risk population would be a logical step to undertake. On the other hand, higher heart rates obviously have a broad differential diagnosis, and the context of every individual patient is different. For instance, a poor level of exercise might be an important factor (in the Western world). 10 Improving activity would then be the answer. Other examples to consider would be hyperthyroidism, chronic obstructive pulmonary disease (COPD), alcohol (mis)use and, evidently, anxiety.
So, it is necessary to take into account what factors produce a (mildly) elevated resting heart rate at the individual level, and what this means for cardiovascular risk.
Moreover, the quality and temperature of air have important effects on cardiovascular function, including measures of heart rate. Ambient particles may exert cardiovascular responses via the autonomous nervous system and oxidative stress. 9 Normal values and the meaning of heart rate may therefore vary according to geographical location.
Prospects and future directions
Since the application of e-health and wrist-worn heart rate monitors -which have demonstrated correlation with ECG measurements 11 -an increasing amount of data is expected to be rapidly available in the near future. Such data with longer follow-up periods may eventually facilitate, and even further improve, the accuracy of the SCORE risk estimates, which are already highly predictive. 7 Although currently the data cannot be regarded as being of direct practical relevance, and caution regarding clinical over-interpretation of the results is appropriate, as a prelude, the study of Archangelidi et al. provides a valuable framework on an emerging and most accessible biomarker.
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